Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system

Neuroscience and Biobehavioral Reviews

Volumn 33, Issue 8, 2009, Pages 1185-1191

  Yu, Long Chuan ^a   Hou, Jun Feng ^a   Fu, Feng Hua ^b   Zhang, Ying Xin ^a  

^a National Laboratory of Biomembrane and Membrane Biotechnology   (China)

^b YANTAI UNIVERSITY   (China)

Author keywords

Antinociception; Calcitonin gene related peptide; Central nervous system; CGRP receptor; CGRP8 37; Pain related behavioral responses

Indexed keywords

AMINO ACID; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; PEPTIDE;

BEHAVIOR; CENTRAL NERVOUS SYSTEM; HUMAN; INFLAMMATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SPINAL CORD;

ANIMALS; BRAIN; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; NOCICEPTORS; PAIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SPINAL CORD;

EID: 69749117292     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.03.009     Document Type: Review

References (66)

1. Adwanikar H., Ji G., Li W., Doods H., Willis W.D., and Neugebauer V. Spinal CGRP1 receptors contribute to supraspinally organized pain behavior and pain-related sensitization of amygdala neurons. Pain 132 (2007) 53-66
2. Bao L., Jin S.X., Zhang C., Wang L.H., Xu Z.Z., Zhang F.X., Wang L.C., Ning F.S., Cai H.J., Guan J.S., Xiao H.S., Xu Z.Q., He C., Hökfelt T., Zhou Z., and Zhang X. Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 37 (2003) 121-133
3. Belanger S., Ma W., Chabot J.G., and Quirion R. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience 115 (2002) 441-453
4. Bennett A.D., Chastain K.M., and Hulsebosch C.E. Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain 86 (2000) 163-175
5. Bird G.C., Han J.S., Fu Y., Adwanikar H., Willis W.D., and Neugebauer V. Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol. Pain 2 (2006) 31-42
6. Bouchard P., Maurice T., St-Pierre S., Privat A., and Quirion R. Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. Eur. J. Neurosci. 9 (1997) 2142-2151
7. Bracci-Laudiero L., Aloe L., Lundeberg T., Theodorsson E., and Stenfors C. Altered levels of neuropeptides characterize the brain of lupus prone mice. Neurosci. Lett. 275 (1999) 57-60
8. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., and Born W. A receptor activity modifying protein (RAMP) 2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 140 (1999) 2883-2890
9. Chen L.Y., and Yu L.C. Involvements of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats. Regul. Peptides (2008) 15143-15147
10. Doods H., Arndt K., Rudolf K., and Just S. CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol. Sci. 28 (2007) 580-587
11. Durham P.L. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine. Headache 48 (2008) 1269-1275
12. Evans B.N., Rosenblatt M.I., Mnayer L.O., Oliver K.R., and Dickerson I.M. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem. 275 (2000) 31438-31443
13. Fitzsimmons T.J., Zhao X., and Wank S.A. The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function. J. Biol. Chem. 278 (2003) 14313-14320
14. Goharkhay N., Lu J., Felix J.C., and Wing D.A. Expression of calcitonin gene-related peptide-receptor component protein (CGRP-RCP) in human myometrium in differing physiological states and following misoprostol administration. Am. J. Perinatol. 24 (2007) 497-500
15. Gu X.L., and Yu L.C. The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study. Neurosci. Lett. 414 (2007) 237-241
16. Gu X.L., and Yu L.C. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats. J. Pain 8 (2007) 85-90
17. Harzenetter M.D., Keller U., Beer S., Riedl C., Peschel C., and Holzmann B. Regulation and function of the CGRP receptor complex in human granulopoiesis. Exp. Hematol. 30 (2002) 306-312
18. Hay D.L. What makes a CGRP2 receptor? Clin. Exp. Pharmac. Physiol. 34 (2007) 963-971
19. Hay D.L., Christopoulos G., Christopoulos A., Poyner D.R., and Sextonm P.M. Pharmacological discrimination of calcitonin receptor-receptor activity modifying protein complexes. Mol. Pharmacol. 67 (2005) 1655-1665
20. Hay D.L., Howitt S.G., Conner A.C., Schindler M., Smith D.M., and Poyner D.R. CL/RAMP2 and CL/RAMP3 produce harmacologically distinct adrenomedullin receptors: A comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. Br. J. Pharmacol. 140 (2003) 477-486
21. Huang Y.H., Brodda-Jansen G., Lundeberg T., and Yu L.C. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain Res. 873 (2000) 54-59
22. Jacques D., Dumont Y., rossum D.V., and Quirion R. Chapter VIII: calcitonin gene-related peptide (CGRP), amylin and adrenomedullin: anatomical localization and biological functions in the mammalian and human brains. Handbook of Chemical Neuroanatomy (2000), Elsevier pp. 301-374
23. Jolicoeur F.B., Menard D., Fournier A., and St-Pierre S. Structure-activity analysis of CGRP's neurobehavioral effects. Ann. NY Acad. Sci. 657 (1992) 155-163
24. Juaneda C., Dumont Y., and Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol. Sci. 21 (2000) 432-438
25. Kovacs A., and Telegdy G. Behavioural impairment induced by calcitonin gene-related peptide (CGRP) antiserum in passive avoidance reflex in rats. Neuropeptides 26 (1994) 233-236
26. Leem J.W., Gwak Y.S., Lee E.H., Chung S.S., Kim Y.S., and Nam T.S. Effects of iontophoretically applied substance P, calcitonin gene-related peptide on excitability of dorsal horn neurones in rats. Yonsei Med. J. 42 (2001) 74-83
27. Li J.J., and Yu L.C. Anti-nociceptive role of neuropeptide Y in the nucleus accumbens in rats with inflammation, an effect modulated by mu- and kappa-opioid receptors. Natural Progress 16 (2006) 133-141
28. Li N., Lundeberg T., and Yu L.C. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats. Brain Res. 901 (2001) 161-166
29. 1A receptors in the descending anti-nociceptive pathway from periaqueductal grey to the spinal dorsal horn in intact rats, rats with mononeuropathy and rats with inflammation. Neuroscience 112 (2002) 399-407
30. Ma W., Chabot J.G., Powell K.J., Jhamandas K., Dickerson I.M., and Quirion R. Localization and modulation of calcitonin gene related peptide receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 120 (2003) 677-694
31. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
32. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 57 (1999) 1-164
33. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
34. Morfis M., Christopoulos A., and Sexton P.M. RAMPs: 5 years on, where to now?. Trends Pharmacol. Sci. 24 (2003) 596-601
35. Nagy G.G., Al-Ayyan M., Andrew D., Fukaya M., Watanabe M., and Todd A.J. Widespread expression of the AMPA receptor GluR2 subunit at glutamatergic synapses in the rat spinal cord and phosphorylation of GluR1 in response to noxious stimulation revealed with an antigen-unmasking method. J. Neurosci. 24 (2004) 5766-5777
36. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89 (2001) 1-15
37. Neugebauer V., Li W., Bird G.C., and Han J.S. The amygdala and persistent pain. Neuroscientist 10 (2004) 221-234
38. Neugebauer V., Rumenapp P., and Schaible H.G. Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat's knee joint and in the generation and maintenance of hyperexcitability of dorsal horn-neurons during development of acute inflammation. Neuroscience 71 (1996) 1095-1109
39. Ohtori S., Takahashi K., Chiba T., Yamagata M., Sameda H., and Moriya H. Phenotypic inflammation switch in rats shown by calcitonin gene-related peptide immunoreactive dorsal root ganglion neurons innervating the lumbar facet joints. Spine 26 (2001) 1009-1013
40. Oku R., Satoh M., Fujii N., Otaka A., Yajima H., and Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 403 (1987) 350-354
41. Oliver K.R., Wainwright A., Heavens R.P., Hill R.G., and Sirinathsinghji D.J. Distribution of novel CGRP1 receptor and adrenomedullin receptor mRNAs in the rat central nervous system. Mol. Brain Res. 57 (1998) 149-154
42. Pin S.S., and Bahr B.A. Protein kinase C is a common component of CGRP receptor desensitization induced by distinct agonists. Eur. J. Pharmacol. 587 (2008) 8-15
43. Powell K.J., Quirion R., and Jhamandas K. Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. Eur. J. Neurosci. 18 (2003) 1572-1583
44. Poyner D.R., Sexton P.M., Marshall I., Smith D.M., Quiron R., Born W., Muff R., Fischer J.A., and Foord S.M. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol. Rev. 54 (2002) 233-246
45. Rosenfeld M.G., Amara S.G., and Evans R.M. Alternative RNA processing: determining neuronal phenotype. Science 225 (1984) 1315-1320
46. Salmon A.M., Damaj M.I., Marubio L.M., Epping-Jordan M.P., Merlo-Pich E., and Changeux J.P. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nat. Neurosci. 4 (2001) 357-358
47. Schaeffer C., Vandroux D., Thomassin L., Athias P., Rochette L., and Connat J.L. Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim. Biophys. Acta Mol. Cell Res. 1643 (2003) 65-73
48. Sun R.Q., Tu Y.J., Lawand N.B., Yan J.Y., Lin Q., and Willis W.D. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J. Neurophysiol. 92 (2004) 2859-2866
49. van Rossum D., Hanisch U.K., and Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 21 (1997) 649-678
50. Wick E.C., Hoge S.G., Grahn S.W., Kim E., Divino L.A., Grady E.F., Bunnett N.W., and Kirkwood K.S. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G959-969
51. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11 (1997) 167-239
52. Xiong W., and Yu L.-C. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats. Neurosci. Lett. 399 (2006) 167-170
53. Xu S.L., Lundeberg T., and Yu L.C. Antinociceptive effects of calcitonin gene-related peptide injected into periaqueductal grey of rats with mononeuropathy. Brain Res. 858 (2000) 358-360
54. Xu W., Lundeberg T., Wang Y.T., Li Y., and Yu L.C. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience 118 (2003) 1015-1022
55. Xu X.J., and Wiesenfeld-Hallin Z. Calcitonin gene-related peptide (8-37) does not antagonize calcitonin gene-related peptide in rat spinal cord. Neurosci. Lett. 204 (1996) 185-188
56. Yan Y., and Yu L.C. Involvement of opioid receptors in CGRP8-37-induced inhibition on the activity of wide dynamic range neurons in the spinal dorsal horn of rats. J. Neurosci. Res. 77 (2004) 148-152
57. Young A. Receptor pharmacology. Adv. Pharmacol. 52 (2005) 47-65
58. Yu L.C., Hansson P., and Lundeberg T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats. Brain Res. 653 (1994) 223-230
59. Yu L.C., Hansson P., and Lundeberg T. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37. Brain Res. 698 (1995) 23-29
60. Yu L.C., Hansson P., Brodda-Jansen G., Theodorsson E., and Lundeberg T. Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation. Br. J. Pharmacol. 117 (1996) 43-50
61. Yu L.C., Hansson P., and Lundeberg T. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone. Neuroscience 71 (1996) 523-531
62. Yu L.C., Weng X.H., Wang J.W., and Lundeberg T. Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats. Neurosci. Lett. 349 (2003) 1-4
63. Yu L.C., Zheng E.M., and Lundeberg T. Calcitonin gene-related peptide 8-37 inhibits the evoked discharge frequency of wide dynamic range neurons in dorsal horn of the spinal cord in rats. Regul. Pept. 83 (1999) 21-24
64. Yu Y., Lundeberg T., and Yu L.C. Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats. Regul. Pept. 103 (2002) 23-27
65. Zhang L., Hoff A.O., Wimalawansa S.J., Cote G.J., Gagel R.F., and Westlund K.N. Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity. Pain 89 (2001) 265-273
66. Zhou X., Li J.J., and Yu L.C. Plastic changes of calcitonin gene-related peptide in morphine tolerance: behavioral and immunohistochemical study in rats. J. Neurosci. Res. 74 (2003) 622-629